Finance

Lists
ZLDPF:OTCMKTS
Zealand Pharma A/S
50,50 $
+6,32%
(+3,00) 1D
7 օգս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLDPF...
Open
50,50 $
High
50,50 $
Low
50,50 $
Mkt. cap
3,66 մլրդ
Avg. vol.
240,00
Volume
1,10 հզր
52-wk high
83,12 $
52-wk low
35,93 $
Beta
1,24
Shares outstanding
71,58 մլն
No. of employees
544
Open
50,50 $
High
50,50 $
Low
50,50 $
Mkt. cap
3,66 մլրդ
Avg. vol.
240,00
Volume
1,10 հզր
52-wk high
83,12 $
52-wk low
35,93 $
Beta
1,24
Shares outstanding
71,58 մլն
No. of employees
544
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees544
Founded01 ապր, 1997 թ.
Headquarters-
Sector-
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
9,09 մլրդ
49,57 մլն
68,92 մլն
34,00 մլն
Cost of goods sold
410,00 հզր
-
-
-
Cost of revenue
410,00 հզր
-
-
-
Research and development expenses
464,14 մլն
320,04 մլն
530,07 մլն
469,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110,46 մլն
190,85 մլն
91,81 մլն
104,00 մլն
Operating expense
749,45 մլն
510,89 մլն
621,88 մլն
573,00 մլն
Total operating expenses
749,86 մլն
510,89 մլն
621,88 մլն
573,00 մլն
Operating income
8,34 մլրդ
-461,32 մլն
-552,97 մլն
-539,00 մլն
Other non operating income
2,98 մլն
-17,59 մլն
-7,23 մլն
24,00 մլն
EBT including unusual items
8,11 մլրդ
-366,73 մլն
-406,51 մլն
-394,00 մլն
EBT excluding unusual items
8,11 մլրդ
-383,62 մլն
-460,20 մլն
-375,00 մլն
Income tax expense
537,32 մլն
37,50 մլն
-27,39 մլն
-
Effective tax rate
6,62%
-10,23%
6,74%
-
Other operating expenses
174,85 մլն
-
1,00 հզր
-
Net income
7,57 մլրդ
-404,23 մլն
-379,12 մլն
-394,00 մլն
Net profit margin
83,33%
-815,50%
-550,12%
-1 158,82%
Earnings per share
105,61
-5,75
-5,19
-5,58
Interest and investment income
56,36 մլն
108,95 մլն
102,41 մլն
74,00 մլն
Interest expense
-7,34 մլն
-7,00 մլն
-7,07 մլն
-5,00 մլն
Net interest expenses
49,02 մլն
101,95 մլն
95,34 մլն
69,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
8,34 մլրդ
-454,10 մլն
-550,48 մլն
-529,00 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google Apps